T1	Participants 55 93	hypopharyngeal squamous cell carcinoma
T2	Participants 265 323	hypopharynx and lateral epilarynx squamous cell carcinoma.
T3	Participants 345 373	Two hundred and two patients
T4	Participants 982 1003	194 eligible patients
T5	Participants 1440 1471	more than half of the survivors
